ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |

(State or Other Jurisdiction
of Incorporation)
|
(IRS Employer
Identification No.)
|
|||
(Address of Principal Executive Offices) |
(Zip Code) |
Title of each class |
Trading Symbol |
Name of each exchange
on which registered
|
||
Class A Common Stock, $0.001 par value per
share |
☒ |
Accelerated filer |
☐ |
Non-accelerated filer |
☐ |
Smaller reporting company |
Emerging growth company |





Year Ended December 31, |
||||||
(in thousands, except percentages and per share data) |
2025 |
2024 |
2023 |
|||
Revenue |
||||||
Net commissions and fees |
$2,994,582 |
$2,455,671 |
$2,026,596 |
|||
Fiduciary investment income |
56,544 |
60,039 |
50,953 |
|||
Total revenue |
$3,051,126 |
$2,515,710 |
$2,077,549 |
|||
Expenses |
||||||
Compensation and benefits |
1,803,397 |
1,591,077 |
1,321,029 |
|||
General and administrative |
453,452 |
352,050 |
276,181 |
|||
Amortization |
274,426 |
157,845 |
106,799 |
|||
Depreciation |
13,089 |
9,785 |
9,038 |
|||
Change in contingent consideration |
13,122 |
(22,859) |
5,421 |
|||
Total operating expenses |
$2,557,486 |
$2,087,898 |
$1,718,468 |
|||
Operating income |
$493,640 |
$427,812 |
$359,081 |
|||
Interest expense, net |
222,384 |
158,448 |
119,507 |
|||
Income from equity method investments |
(21,236) |
(18,231) |
(8,731) |
|||
Other non-operating loss (income) |
(692) |
15,041 |
10,380 |
|||
Income before income taxes |
$293,184 |
$272,554 |
$237,925 |
|||
Income tax expense |
79,027 |
42,641 |
43,445 |
|||
Net income |
$214,157 |
$229,913 |
$194,480 |
|||
GAAP financial measures |
||||||
Revenue |
$3,051,126 |
$2,515,710 |
$2,077,549 |
|||
Net commissions and fees |
2,994,582 |
2,455,671 |
2,026,596 |
|||
Compensation and benefits |
1,803,397 |
1,591,077 |
1,321,029 |
|||
General and administrative |
453,452 |
352,050 |
276,181 |
|||
Net income |
214,157 |
229,913 |
194,480 |
|||
Compensation and benefits expense ratio (1) |
59.1% |
63.2% |
63.6% |
|||
General and administrative expense ratio (2) |
14.9% |
14.0% |
13.3% |
|||
Net income margin (3) |
7.0% |
9.1% |
9.4% |
|||
Earnings per share (4) |
$0.50 |
$0.78 |
$0.53 |
|||
Diluted earnings per share (4) |
$0.47 |
$0.71 |
$0.52 |
|||
Non-GAAP financial measures* |
||||||
Organic revenue growth rate |
10.1% |
12.8% |
15.4% |
|||
Adjusted compensation and benefits expense |
$1,692,000 |
$1,426,674 |
$1,222,342 |
|||
Adjusted compensation and benefits expense ratio |
55.5% |
56.7% |
58.8% |
|||
Adjusted general and administrative expense |
$392,384 |
$277,813 |
$230,467 |
|||
Adjusted general and administrative expense ratio |
12.9% |
11.0% |
11.1% |
|||
Adjusted EBITDAC |
$966,742 |
$811,223 |
$624,740 |
|||
Adjusted EBITDAC margin |
31.7% |
32.2% |
30.1% |
|||
Adjusted net income |
$548,219 |
$493,521 |
$375,582 |
|||
Adjusted net income margin |
18.0% |
19.6% |
18.1% |
|||
Adjusted diluted earnings per share |
$1.96 |
$1.79 |
$1.38 |
|||
Year Ended December 31,
|
Period over Period
|
|||||||||||
(in thousands, except
percentages)
|
2025 |
% of
total
|
2024 |
% of
total
|
Change
|
|||||||
Wholesale Brokerage |
$1,600,427 |
53.4% |
$1,489,077 |
60.7% |
$111,350 |
7.5% |
||||||
Binding Authority |
370,155 |
12.4 |
320,379 |
13.0 |
49,776 |
15.5 |
||||||
Underwriting Management |
1,024,000 |
34.2 |
646,215 |
26.3 |
377,785 |
58.5 |
||||||
Total Net commissions
and fees
|
$2,994,582 |
$2,455,671 |
$538,911 |
21.9% |
||||||||
Year Ended December 31,
|
Period over Period
|
|||||||||||
(in thousands, except
percentages)
|
2025 |
% of
total
|
2024 |
% of
total
|
Change
|
|||||||
Net commissions and
policy fees
|
$2,759,597 |
92.1% |
$2,310,384 |
94.1% |
$449,213 |
19.4% |
||||||
Supplemental and
contingent commissions
|
149,237 |
5.0 |
88,842 |
3.6 |
60,395 |
68.0 |
||||||
Loss mitigation and other
fees
|
85,748 |
2.9 |
56,445 |
2.3 |
29,303 |
51.9 |
||||||
Total Net commissions
and fees
|
$2,994,582 |
$2,455,671 |
$538,911 |
21.9% |
||||||||
Year Ended December 31,
|
Period over Period
|
|||||||||||
(in thousands, except
percentages)
|
2024 |
% of
total
|
2023 |
% of
total
|
Change
|
|||||||
Wholesale Brokerage |
$1,489,077 |
60.7% |
$1,319,056 |
65.1% |
$170,021 |
12.9% |
||||||
Binding Authority |
320,379 |
13.0 |
275,961 |
13.6 |
44,418 |
16.1 |
||||||
Underwriting Management |
646,215 |
26.3 |
431,579 |
21.3 |
214,636 |
49.7 |
||||||
Total Net commissions
and fees
|
$2,455,671 |
$2,026,596 |
$429,075 |
21.2% |
||||||||
Year Ended December 31,
|
Period over Period
|
|||||||||||
(in thousands, except
percentages)
|
2024 |
% of
total
|
2023 |
% of
total
|
Change
|
|||||||
Net commissions and
policy fees
|
$2,310,384 |
94.1% |
$1,935,851 |
95.5% |
$374,533 |
19.3% |
||||||
Supplemental and
contingent commissions
|
88,842 |
3.6 |
56,375 |
2.8 |
32,467 |
57.6 |
||||||
Loss mitigation and other
fees
|
56,445 |
2.3 |
34,370 |
1.7 |
22,075 |
64.2 |
||||||
Total Net commissions
and fees
|
$2,455,671 |
$2,026,596 |
$429,075 |
21.2% |
||||||||
Year Ended December 31, |
||||||
(in thousands, except percentages) |
2025 |
2024 |
2023 |
|||
Current period Net commissions and fees revenue |
$2,994,582 |
$2,455,671 |
$2,026,596 |
|||
Less: Current period contingent commissions |
(121,549) |
(73,175) |
(39,028) |
|||
Less: Revenue attributable to sold businesses |
(361) |
— |
— |
|||
Net commissions and fees revenue
excluding contingent commissions
|
$2,872,672 |
$2,382,496 |
$1,987,568 |
|||
Prior period Net commissions and fees revenue |
$2,455,671 |
$2,026,596 |
$1,711,861 |
|||
Less: Prior period contingent commissions |
(73,175) |
(39,028) |
(30,788) |
|||
Less: Revenue attributable to sold businesses |
(1,941) |
— |
— |
|||
Prior period Net commissions and fees revenue
excluding contingent commissions
|
$2,380,555 |
$1,987,568 |
$1,681,073 |
|||
Change in Net commissions and fees revenue excluding
contingent commissions
|
$492,117 |
$394,928 |
$306,494 |
|||
Less: Mergers and acquisitions Net commissions and fees
revenue excluding contingent commissions
|
(246,914) |
(141,972) |
(46,496) |
|||
Impact of change in foreign exchange rates |
(4,863) |
(791) |
(479) |
|||
Organic revenue growth (Non-GAAP) |
$240,340 |
$252,165 |
$259,519 |
|||
Net commissions and fees revenue growth rate (GAAP) |
21.9 % |
21.2 % |
18.4 % |
|||
Less: Impact of contingent commissions (1) |
(1.2) |
(1.3) |
(0.2) |
|||
Net commissions and fees revenue
excluding contingent commissions growth rate (2)
|
20.7 % |
19.9 % |
18.2 % |
|||
Less: Mergers and acquisitions Net commissions and fees
revenue excluding contingent commissions (3)
|
(10.4) |
(7.1) |
(2.8) |
|||
Impact of change in foreign exchange rates (4) |
(0.2) |
0.0 |
0.0 |
|||
Organic Revenue Growth Rate (Non-GAAP) |
10.1 % |
12.8 % |
15.4 % |
|||
Year Ended December 31,
|
||||||
(in thousands, except percentages) |
2025 |
2024 |
2023 |
|||
Total Revenue |
$3,051,126 |
$2,515,710 |
$2,077,549 |
|||
Compensation and Benefits Expense |
$1,803,397 |
$1,591,077 |
$1,321,029 |
|||
Acquisition-related expense |
(11,033) |
(15,373) |
(4,186) |
|||
Acquisition related long-term incentive compensation (1) |
(26,581) |
(24,946) |
4,334 |
|||
Restructuring and related expense |
— |
(39,929) |
(22,651) |
|||
Amortization and expense related to discontinued prepaid
incentives
|
(4,332) |
(5,160) |
(6,441) |
|||
Equity-based compensation (2) |
(49,664) |
(52,038) |
(31,047) |
|||
IPO related expenses |
(19,787) |
(26,957) |
(38,696) |
|||
Adjusted Compensation and Benefits Expense (3) |
$1,692,000 |
$1,426,674 |
$1,222,342 |
|||
Compensation and Benefits Expense Ratio |
59.1% |
63.2% |
63.6% |
|||
Adjusted Compensation and Benefits Expense Ratio |
55.5% |
56.7% |
58.8% |
|||
Year Ended December 31,
|
||||||
(in thousands, except percentages) |
2025 |
2024 |
2023 |
|||
Total Revenue |
$3,051,126 |
$2,515,710 |
$2,077,549 |
|||
General and Administrative Expense |
$453,452 |
$352,050 |
$276,181 |
|||
Acquisition-related expense |
(61,068) |
(54,469) |
(19,088) |
|||
Restructuring and related expense |
— |
(19,768) |
(26,626) |
|||
Adjusted General and Administrative Expense (1) |
$392,384 |
$277,813 |
$230,467 |
|||
General and Administrative Expense Ratio |
14.9% |
14.0% |
13.3% |
|||
Adjusted General and Administrative Expense Ratio |
12.9% |
11.0% |
11.1% |
|||
Year Ended December 31,
|
||||||
(in thousands, except percentages) |
2025 |
2024 |
2023 |
|||
Total Revenue |
$3,051,126 |
$2,515,710 |
$2,077,549 |
|||
Net Income |
$214,157 |
$229,913 |
$194,480 |
|||
Interest expense, net |
222,384 |
158,448 |
119,507 |
|||
Income tax expense |
79,027 |
42,641 |
43,445 |
|||
Depreciation |
13,089 |
9,785 |
9,038 |
|||
Amortization |
274,426 |
157,845 |
106,799 |
|||
Change in contingent consideration (1) |
13,122 |
(22,859) |
5,421 |
|||
EBITDAC |
$816,205 |
$575,773 |
$478,690 |
|||
Acquisition-related expense |
72,101 |
69,842 |
23,274 |
|||
Acquisition related long-term incentive compensation (2) |
26,581 |
24,946 |
(4,334) |
|||
Restructuring and related expense |
— |
59,697 |
49,277 |
|||
Amortization and expense related to discontinued prepaid incentives |
4,332 |
5,160 |
6,441 |
|||
Other non-operating loss (income) |
(692) |
15,041 |
10,380 |
|||
Equity-based compensation |
49,664 |
52,038 |
31,047 |
|||
IPO related expenses |
19,787 |
26,957 |
38,696 |
|||
Income from equity method investments |
(21,236) |
(18,231) |
(8,731) |
|||
Adjusted EBITDAC |
$966,742 |
$811,223 |
$624,740 |
|||
Net Income Margin |
7.0% |
9.1% |
9.4% |
|||
Adjusted EBITDAC Margin |
31.7% |
32.2% |
30.1% |
|||
Year Ended December 31,
|
||||||
(in thousands, except percentages) |
2025 |
2024 |
2023 |
|||
Total Revenue |
$3,051,126 |
$2,515,710 |
$2,077,549 |
|||
Net Income |
$214,157 |
$229,913 |
$194,480 |
|||
Income tax expense |
79,027 |
42,641 |
43,445 |
|||
Amortization |
274,426 |
157,845 |
106,799 |
|||
Amortization of deferred debt issuance costs (1) |
9,567 |
23,930 |
12,172 |
|||
Change in contingent consideration |
13,122 |
(22,859) |
5,421 |
|||
Acquisition-related expense |
72,101 |
69,842 |
23,274 |
|||
Acquisition related long-term incentive compensation |
26,581 |
24,946 |
(4,334) |
|||
Restructuring and related expense |
— |
59,697 |
49,277 |
|||
Amortization and expense related to discontinued prepaid incentives |
4,332 |
5,160 |
6,441 |
|||
Other non-operating loss (income) |
(692) |
15,041 |
10,380 |
|||
Equity-based compensation |
49,664 |
52,038 |
31,047 |
|||
IPO related expenses |
19,787 |
26,957 |
38,696 |
|||
Income from equity method investments |
(21,236) |
(18,231) |
(8,731) |
|||
Adjusted Income before Income Taxes (2) |
$740,836 |
$666,920 |
$508,367 |
|||
Adjusted tax expense (3) |
(192,617) |
(173,399) |
(132,785) |
|||
Adjusted Net Income |
$548,219 |
$493,521 |
$375,582 |
|||
Net Income Margin |
7.0% |
9.1% |
9.4% |
|||
Adjusted Net Income Margin |
18.0% |
19.6% |
18.1% |
|||
Year Ended December 31, |
||||||
2025 |
2024 |
2023 |
||||
Earnings per share of Class A common stock – diluted |
$0.47 |
$0.71 |
$0.52 |
|||
Less: Net income attributed to dilutive shares and substantively vested
RSUs (1)
|
(0.01) |
— |
(0.03) |
|||
Plus: Impact of all LLC Common Units exchanged for Class A shares
(2)
|
0.32 |
0.14 |
0.24 |
|||
Plus: Adjustments to Adjusted net income (3) |
1.22 |
0.97 |
0.67 |
|||
Plus: Dilutive impact of unvested equity awards (4) |
(0.04) |
(0.03) |
(0.02) |
|||
Adjusted diluted earnings per share |
$1.96 |
$1.79 |
$1.38 |
|||
(Share count in ’000s) |
||||||
Weighted-average shares of Class A common stock outstanding –
diluted
|
138,246 |
132,891 |
125,745 |
|||
Plus: Impact of all LLC Common Units exchanged for Class A shares
(2)
|
135,429 |
138,980 |
142,384 |
|||
Plus: Dilutive impact of unvested equity awards (4) |
5,354 |
4,417 |
4,137 |
|||
Adjusted diluted earnings per share diluted share count |
279,029 |
276,288 |
272,266 |
|||
(in thousands) |
Exchange Tax
Attributes
|
Pre-IPO M&A
Tax Attributes
|
TRA Payment
Tax Attributes
|
TRA
Liabilities
|
||||
Balance at December 31, 2024 |
$253,233 |
$83,415 |
$99,648 |
$436,296 |
||||
Exchange of LLC Common Units |
34,813 |
2,466 |
9,479 |
46,758 |
||||
Interest expense |
— |
— |
1,112 |
1,112 |
||||
Payments |
(16,067) |
(8,532) |
(570) |
(25,169) |
||||
Balance at December 31, 2025 |
$271,979 |
$77,349 |
$109,669 |
$458,997 |
Long-term Incentive Compensation Agreements |
||
(in thousands) |
December 31, 2025 |
|
Current accrued compensation |
$10,752 |
|
Non-current accrued compensation |
19,212 |
|
Total liability |
$29,963 |
|
Projected future expense |
44,880 |
|
Total projected future cash outflows |
$74,843 |
|
Projected Future Cash Outflows |
||
(in thousands) |
||
2026 |
$14,632 |
|
2027 |
9,274 |
|
2028 |
32,257 |
|
2029 |
11,048 |
|
Thereafter |
$7,632 |
|
Contingent Consideration |
||
(in thousands) |
December 31, 2025 |
|
Current accounts payable and accrued liabilities |
$55,880 |
|
Other non-current liabilities |
92,508 |
|
Total liability |
$148,388 |
|
Projected future expense |
10,429 |
|
Total projected future cash outflows |
$158,817 |
|
Projected Future Cash Outflows |
||
(in thousands) |
||
2026 |
$57,255 |
|
2027 |
89,016 |
|
2028 |
6,262 |
|
2029 |
4,662 |
|
Thereafter |
$1,622 |
|
(in thousands) |
Balance at
December 31, 2025
|
100 BPS
Increase
|
100 BPS
Decrease
|
|||
Cash and cash equivalents |
$158,322 |
$(1,583) |
$1,583 |
|||
Term Loan principal outstanding (1) |
1,683,000 |
16,830 |
$(16,830) |
|||
Net exposure to Interest expense, net |
15,247 |
(15,247) |
||||
Cash and cash equivalents held in a fiduciary capacity |
1,426,148 |
14,261 |
$(14,261) |
|||
Net exposure to Fiduciary investment income |
$14,261 |
$(14,261) |
||||
Impact to Net income |
$(985) |
$985 |
Consolidated Statements of Comprehensive Income for the years ended December 31, 2025, 2024, and 2023
|
|
Consolidated Statements of Stockholders’ Equity for the years ended December 31, 2025, 2024, and 2023
|
|
Year Ended December 31, |
||||||
2025 |
2024 |
2023 |
||||
REVENUE |
||||||
Net commissions and fees |
$ |
$ |
$ |
|||
Fiduciary investment income |
||||||
Total revenue |
$ |
$ |
$ |
|||
EXPENSES |
||||||
Compensation and benefits |
||||||
General and administrative |
||||||
Amortization |
||||||
Depreciation |
||||||
Change in contingent consideration |
( |
|||||
Total operating expenses |
$ |
$ |
$ |
|||
OPERATING INCOME |
$ |
$ |
$ |
|||
Interest expense, net |
||||||
Income from equity method investments |
( |
( |
( |
|||
Other non-operating loss (income) |
( |
|||||
INCOME BEFORE INCOME TAXES |
$ |
$ |
$ |
|||
Income tax expense |
||||||
NET INCOME |
$ |
$ |
$ |
|||
Net income attributable to non-controlling interests, net of tax |
||||||
NET INCOME ATTRIBUTABLE TO RYAN SPECIALTY
HOLDINGS, INC.
|
$ |
$ |
$ |
|||
NET INCOME PER SHARE OF CLASS A COMMON
STOCK:
|
||||||
Basic |
$ |
$ |
$ |
|||
Diluted |
$ |
$ |
$ |
|||
WEIGHTED-AVERAGE SHARES OF CLASS A COMMON
STOCK OUTSTANDING:
|
||||||
Basic |
||||||
Diluted |
||||||
Year Ended December 31, |
||||||
2025 |
2024 |
2023 |
||||
NET INCOME |
$ |
$ |
$ |
|||
Net income attributable to non-controlling interests, net of tax |
||||||
NET INCOME ATTRIBUTABLE TO RYAN SPECIALTY
HOLDINGS, INC.
|
$ |
$ |
$ |
|||
Other comprehensive income (loss), net of tax: |
||||||
Gain on interest rate cap |
||||||
Gain on interest rate cap reclassified to earnings |
( |
( |
( |
|||
Foreign currency translation adjustments |
( |
|||||
Change in share of equity method investments’ other
comprehensive income (loss)
|
( |
|||||
Total other comprehensive income (loss), net of tax |
$ |
$( |
$( |
|||
COMPREHENSIVE INCOME ATTRIBUTABLE TO RYAN
SPECIALTY HOLDINGS, INC.
|
$ |
$ |
$ |
|||
December 31, 2025 |
December 31, 2024 |
|||
ASSETS |
||||
CURRENT ASSETS |
||||
Cash and cash equivalents |
$ |
$ |
||
Commissions and fees receivable – net |
||||
Fiduciary cash and receivables |
||||
Prepaid incentives – net |
||||
Other current assets |
||||
Total current assets |
$ |
$ |
||
NON-CURRENT ASSETS |
||||
Goodwill |
||||
Customer relationships |
||||
Other intangible assets |
||||
Prepaid incentives – net |
||||
Equity method investments |
||||
Property and equipment – net |
||||
Lease right-of-use assets |
||||
Deferred tax assets |
||||
Other non-current assets |
||||
Total non-current assets |
$ |
$ |
||
TOTAL ASSETS |
$ |
$ |
||
LIABILITIES AND STOCKHOLDERS’ EQUITY |
||||
CURRENT LIABILITIES |
||||
Accounts payable and accrued liabilities |
$ |
$ |
||
Accrued compensation |
||||
Operating lease liabilities |
||||
Short-term debt and current portion of long-term debt |
||||
Fiduciary liabilities |
||||
Total current liabilities |
$ |
$ |
||
NON-CURRENT LIABILITIES |
||||
Accrued compensation |
||||
Operating lease liabilities |
||||
Long-term debt |
||||
Tax Receivable Agreement liabilities |
||||
Deferred tax liabilities |
||||
Other non-current liabilities |
||||
Total non-current liabilities |
$ |
$ |
||
TOTAL LIABILITIES |
$ |
$ |
||
STOCKHOLDERS’ EQUITY |
||||
Class A common stock ($
shares issued and outstanding at December 31, 2025 and 2024, respectively)
|
||||
Class B common stock ($
shares issued and outstanding at December 31, 2025 and 2024, respectively)
|
||||
Class X common stock ($
|
||||
Preferred stock ($
December 31, 2025 and 2024)
|
||||
Additional paid-in capital |
||||
Retained earnings |
||||
Accumulated other comprehensive income (loss) |
( |
|||
Total stockholders’ equity attributable to Ryan Specialty Holdings, Inc. |
$ |
$ |
||
Non-controlling interests |
||||
Total stockholders’ equity |
$ |
$ |
||
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY |
$ |
$ |
Year Ended December 31, |
||||||
2025 |
2024 |
2023 |
||||
CASH FLOWS FROM OPERATING ACTIVITIES |
||||||
Net income |
$ |
$ |
$ |
|||
Adjustments to reconcile net income to cash flows provided by operating activities: |
||||||
Income from equity method investments |
( |
( |
( |
|||
Amortization |
||||||
Depreciation |
||||||
Prepaid and deferred compensation expense |
||||||
Non-cash equity-based compensation |
||||||
Amortization of deferred debt issuance costs |
||||||
Amortization of interest rate cap premium |
||||||
Deferred income tax expense |
||||||
Deferred income tax expense from common control reorganizations |
||||||
Loss (gain) on Tax Receivable Agreement |
( |
|||||
Changes in operating assets and liabilities, net of acquisitions: |
||||||
Commissions and fees receivable – net |
( |
( |
( |
|||
Accrued interest liability |
||||||
Other current and non-current assets |
( |
|||||
Other current and non-current liabilities |
( |
|||||
Total cash flows provided by operating activities |
$ |
$ |
$ |
|||
CASH FLOWS FROM INVESTING ACTIVITIES |
||||||
Business combinations – net of cash acquired and cash held in a fiduciary capacity |
( |
( |
( |
|||
Capital expenditures |
( |
( |
( |
|||
Equity method investment in VSIC |
( |
|||||
Asset acquisitions |
( |
|||||
Repayments of prepaid incentives |
||||||
Total cash flows used in investing activities |
$( |
$( |
$( |
|||
CASH FLOWS FROM FINANCING ACTIVITIES |
||||||
Proceeds from Senior Secured Notes |
||||||
Borrowings on Revolving Credit Facility |
||||||
Repayments on Revolving Credit Facility |
( |
( |
||||
Debt issuance costs paid |
( |
( |
||||
Proceeds from term debt |
||||||
Repayment of term debt |
( |
( |
( |
|||
Receipt of contingently returnable consideration |
||||||
Payment of contingent consideration |
( |
( |
||||
Tax distributions to non-controlling LLC Unitholders |
( |
( |
( |
|||
Receipt of taxes related to net share settlement of equity awards |
||||||
Taxes paid related to net share settlement of equity awards |
( |
( |
( |
|||
Payment of Tax Receivable Agreement liabilities |
( |
( |
( |
|||
Class A common stock dividends and Dividend Equivalents paid |
( |
( |
||||
Distributions and Declared Distributions paid to non-controlling LLC Unitholders |
( |
( |
||||
Payments related to Ryan Re preferred units |
( |
( |
||||
Net change in fiduciary liabilities |
||||||
Total cash flows provided by (used in) financing activities |
$ |
$ |
$( |
|||
Effect of changes in foreign exchange rates on cash, cash equivalents, and cash and
cash equivalents held in a fiduciary capacity
|
( |
|||||
NET CHANGE IN CASH, CASH EQUIVALENTS, AND CASH AND CASH
EQUIVALENTS HELD IN A FIDUCIARY CAPACITY
|
$( |
$( |
$( |
|||
CASH, CASH EQUIVALENTS, AND CASH AND CASH EQUIVALENTS HELD
IN A FIDUCIARY CAPACITY—Beginning balance
|
||||||
CASH, CASH EQUIVALENTS, AND CASH AND CASH EQUIVALENTS HELD
IN A FIDUCIARY CAPACITY—Ending balance
|
$ |
$ |
$ |
|||
Reconciliation of cash, cash equivalents, and cash and cash equivalents held in a
fiduciary capacity
|
||||||
Cash and cash equivalents |
$ |
$ |
$ |
|||
Cash and cash equivalents held in a fiduciary capacity |
||||||
Total cash, cash equivalents, and cash and cash equivalents held in a fiduciary
capacity
|
$ |
$ |
$ |
|||
Class A
Common Stock
|
Class B
Common Stock
|
Additional
Paid-in
Capital
|
Retained
Earnings
|
Accumulated
Other
Comprehensive
Income (Loss)
|
Non-
controlling
Interests
|
Total
Stockholders’
Equity
|
||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||
Balance at December 31, 2022 |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
|||||||||||
Net income |
— |
— |
— |
— |
— |
— |
||||||||||||
Issuance of common stock |
— |
— |
||||||||||||||||
Forfeiture and retirement of common stock and
clawback of vested equity awards
|
( |
— |
— |
— |
( |
— |
— |
( |
||||||||||
Exchange of LLC equity for common stock |
( |
( |
— |
— |
( |
|||||||||||||
Equity awards withheld for settlement of employee tax
obligations
|
— |
— |
— |
— |
— |
— |
— |
( |
( |
|||||||||
Tax Receivable Agreement liability and deferred taxes
arising from LLC interest ownership changes
|
— |
— |
— |
— |
( |
— |
— |
( |
||||||||||
Distributions declared for non-controlling interest
holders’ tax
|
— |
— |
— |
— |
— |
— |
— |
( |
( |
|||||||||
Change in share of equity method investment’s other
comprehensive loss
|
— |
— |
— |
— |
— |
— |
( |
( |
( |
|||||||||
Loss on interest rate cap, net |
— |
— |
— |
— |
— |
— |
( |
( |
( |
|||||||||
Foreign currency translation adjustments |
— |
— |
— |
— |
— |
— |
||||||||||||
Equity-based compensation |
— |
— |
— |
— |
— |
— |
||||||||||||
Balance at December 31, 2023 |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
|||||||||||
Net income |
— |
— |
— |
— |
— |
— |
||||||||||||
Issuance of common stock |
— |
— |
— |
|||||||||||||||
Forfeiture and retirement of common stock and
clawback of vested equity awards
|
( |
— |
— |
— |
( |
— |
— |
( |
||||||||||
Exchange of LLC equity for common stock |
( |
( |
— |
— |
( |
|||||||||||||
Equity awards withheld for settlement of employee tax
obligations
|
— |
— |
— |
— |
— |
— |
— |
( |
( |
|||||||||
Class A common stock dividends and Dividend
Equivalents
|
— |
— |
— |
— |
— |
( |
— |
— |
( |
|||||||||
Distributions and Declared Distributions to non-
controlling LLC Unitholders
|
— |
— |
— |
— |
— |
— |
— |
( |
( |
|||||||||
Tax Receivable Agreement liability and deferred taxes
arising from LLC interest ownership changes
|
— |
— |
— |
— |
( |
— |
— |
|||||||||||
Distributions declared for non-controlling interest
holders’ tax
|
— |
— |
— |
— |
— |
— |
— |
( |
( |
|||||||||
Change in share of equity method investment’s other
comprehensive income
|
— |
— |
— |
— |
— |
— |
||||||||||||
Loss on interest rate cap, net |
— |
— |
— |
— |
— |
— |
( |
( |
( |
|||||||||
Foreign currency translation adjustments |
— |
— |
— |
— |
— |
— |
( |
( |
( |
|||||||||
Equity-based compensation |
— |
— |
— |
— |
— |
— |
||||||||||||
Balance at December 31, 2024 |
$ |
$ |
$ |
$ |
$( |
$ |
$ |
|||||||||||
Class A
Common Stock
|
Class B
Common Stock
|
Additional
Paid-in
Capital
|
Retained
Earnings
|
Accumulated
Other
Comprehensive
Income (Loss)
|
Non-
controlling
Interests
|
Total
Stockholders’
Equity
|
||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||
Balance at December 31, 2024 |
$ |
$ |
$ |
$ |
$( |
$ |
$ |
|||||||||||
Net income |
— |
— |
— |
— |
— |
— |
||||||||||||
Issuance of common stock |
— |
— |
||||||||||||||||
Cash and common stock clawbacks related to vested
equity awards
|
( |
— |
— |
— |
( |
— |
||||||||||||
Exchange of LLC equity for common stock |
( |
( |
— |
— |
( |
|||||||||||||
Equity awards withheld for settlement of employee tax
obligations
|
— |
— |
— |
— |
( |
— |
— |
( |
( |
|||||||||
Class A common stock dividends and Dividend
Equivalents
|
— |
— |
— |
— |
— |
( |
— |
— |
( |
|||||||||
Distributions and Declared Distributions to non-
controlling LLC Unitholders
|
— |
— |
— |
— |
— |
— |
— |
( |
( |
|||||||||
Tax Receivable Agreement liability and deferred taxes
arising from LLC interest ownership changes
|
— |
— |
— |
— |
( |
— |
— |
( |
||||||||||
Distributions declared for non-controlling interest
holders’ tax
|
— |
— |
— |
— |
— |
— |
— |
( |
( |
|||||||||
Change in share of equity method investments’ other
comprehensive income
|
— |
— |
— |
— |
— |
— |
||||||||||||
Loss on interest rate cap, net |
— |
— |
— |
— |
— |
— |
( |
( |
( |
|||||||||
Foreign currency translation adjustments |
— |
— |
— |
— |
— |
— |
||||||||||||
Equity-based compensation |
— |
— |
— |
— |
— |
— |
||||||||||||
Balance at December 31, 2025 |
$ |
$ |
$ |
$ |
$ |
$ |
$ |
|||||||||||
Year Ended December 31, |
||||||
2025 |
2024 |
2023 |
||||
Wholesale Brokerage |
$ |
$ |
$ |
|||
Binding Authority |
||||||
Underwriting Management |
||||||
Total Net commissions and fees |
$ |
$ |
$ |
|||
Velocity |
USQ |
360 |
JM Wilson |
SSRU |
Total |
|||||||
Cash and cash equivalents |
$ |
$ |
$ |
$ |
$ |
$ |
||||||
Commissions and fees receivable – net |
||||||||||||
Fiduciary cash and receivables |
||||||||||||
Goodwill |
||||||||||||
Customer relationships1
|
||||||||||||
Other intangible assets |
||||||||||||
Property and equipment – net |
||||||||||||
Lease right-of-use assets |
||||||||||||
Other current and non-current assets |
||||||||||||
Total assets acquired |
$ |
$ |
$ |
$ |
$ |
$ |
||||||
Accounts payable and accrued liabilities |
||||||||||||
Accrued compensation |
||||||||||||
Fiduciary liabilities |
||||||||||||
Operating lease liabilities |
||||||||||||
Deferred tax liabilities |
||||||||||||
Total liabilities assumed |
$ |
$ |
$ |
$ |
$ |
$ |
||||||
Net assets acquired |
$ |
$ |
$ |
$ |
$ |
$ |
Year Ended December 31, |
||||||
2025 |
2024 |
2023 |
||||
Total revenue |
$ |
$ |
$ |
|||
Net income |
||||||
Year Ended December 31, |
||||||
2025 |
2024 |
2023 |
||||
Change in contingent consideration |
$ |
$( |
$ |
|||
Interest expense, net |
||||||
Total |
$ |
$( |
$ |
|||
Year Ended December 31, |
||||
2025 |
2024 |
|||
Balance at beginning of period |
$ |
$ |
||
Write-offs |
( |
( |
||
Increase in provision |
||||
Balance at end of period |
$ |
$ |
||
As of December 31, |
||||
2025 |
2024 |
|||
Prepaid expenses |
$ |
$ |
||
Insurance recoverable |
||||
Interest rate cap |
||||
Other current receivables |
||||
Total Other current assets |
$ |
$ |
||
Year Ended December 31, |
||||
2025 |
2024 |
|||
Balance at beginning of period |
$ |
$ |
||
Acquisitions1
|
||||
Measurement period adjustments |
||||
Impact of exchange rate changes |
( |
|||
Balance at end of period |
$ |
$ |
||
As of December 31, 2025 |
As of December 31, 2024 |
|||||||||||
Cost |
Accumulated
Amortization
|
Net Carrying
Amount
|
Cost |
Accumulated
Amortization
|
Net Carrying
Amount
|
|||||||
Customer
relationships
|
$ |
$( |
$ |
$ |
$( |
$ |
||||||
Internally
developed
software
|
( |
( |
||||||||||
Other1
|
( |
( |
||||||||||
Total |
$ |
$( |
$ |
$ |
$( |
$ |
||||||
Customer
Relationships
|
Internally
Developed Software
|
Other |
||||
2026 |
$ |
$ |
$ |
|||
2027 |
||||||
2028 |
||||||
2029 |
||||||
2030 |
||||||
Thereafter |
||||||
Total |
$ |
$ |
$ |
Year Ended December 31, |
||||||
2025 |
2024 |
2023 |
||||
Lease costs |
||||||
Operating lease costs |
$ |
$ |
$ |
|||
Short-term lease costs |
||||||
Operating lease costs |
||||||
Sublease income |
( |
( |
( |
|||
Lease costs – net |
$ |
$ |
$ |
|||
Cash paid for amounts included in the measurement of lease
liabilities
|
||||||
Operating cash flows used for operating leases |
$ |
$ |
$ |
|||
Non-cash related activities |
||||||
Right-of-use assets obtained in exchange for new operating lease
liabilities
|
||||||
Amortization of right-of-use assets for operating leases |
||||||
Weighted-average discount rate (percent) |
||||||
Operating leases |
||||||
Weighted-average remaining lease term (years) |
||||||
Operating leases |
||||||
2026 |
$ |
|
2027 |
||
2028 |
||
2029 |
||
2030 |
||
Thereafter |
||
Total undiscounted future lease payments |
$ |
|
Less: Imputed interest |
( |
|
Present value lease liabilities |
$ |
As of December 31, |
||||
2025 |
2024 |
|||
Term debt |
||||
Adjusted Term SOFR +
SOFR +
|
$ |
$ |
||
Senior secured notes |
||||
February 1, 2030
|
||||
August 1, 2032
|
||||
Revolving debt |
||||
SOFR + up to
July 30, 2029
|
||||
Premium financing notes |
||||
Commercial notes, periodic interest and principal payments,
expire May 1, 2026
|
||||
Commercial notes, periodic interest and principal payments,
expire June 1, 2026
|
||||
Commercial notes, periodic interest and principal payments,
expire June 21, 2026
|
||||
Commercial notes, periodic interest and principal payments,
expired May 1, 2025
|
||||
Commercial notes, periodic interest and principal payments,
expired June 1, 2025
|
||||
Commercial notes, periodic interest and principal payments,
expired June 21, 2025
|
||||
Units subject to mandatory redemption |
||||
Total debt |
$ |
$ |
||
Less: Short-term debt and current portion of long-term debt |
( |
( |
||
Long-term debt |
$ |
$ |
||
2026 |
$ |
|
2027 |
||
2028 |
||
2029 |
||
2030 |
||
Thereafter |
||
Total repayments |
$ |
|
Less: Unamortized discounts and debt issuance costs |
( |
|
Total |
$ |
Year Ended December 31, 2025 |
||||||||
Restricted Stock
|
Weighted
Average Grant
Date Fair Value
|
Restricted
Common Units
|
Weighted
Average Grant
Date Fair Value
|
|||||
Unvested at beginning of period |
$ |
$ |
||||||
Granted |
||||||||
Vested |
( |
( |
||||||
Forfeited |
( |
|||||||
Unvested at end of period |
$ |
$ |
||||||
Year Ended December 31, 2025 |
||||||||
IPO RSUs |
Incentive RSUs |
|||||||
Restricted
Stock Units
|
Weighted
Average Grant
Date Fair Value
|
Restricted
Stock Units
|
Weighted
Average Grant
Date Fair Value
|
|||||
Unvested at beginning of period |
$ |
$ |
||||||
Granted |
||||||||
Vested |
( |
( |
||||||
Forfeited |
( |
( |
||||||
Unvested at end of period |
$ |
$ |
||||||
Year Ended December 31, 2025 |
||||||||
Reload Options1
|
Staking Options1
|
Incentive
Options
|
Incentive Options
Weighted
Average Exercise
Price
|
|||||
Outstanding at beginning of period |
$ |
|||||||
Granted |
||||||||
Exercised |
( |
( |
||||||
Forfeited or expired |
( |
( |
||||||
Outstanding at end of period |
$ |
|||||||
Volatility |
||
Time to maturity (years) |
||
Risk-free rate |
||
Dividend yield |
||
Fair value per option |
$ |
Aggregate intrinsic value ($ in thousands): |
||
Reload Options outstanding |
$ |
|
Reload Options exercisable |
||
Staking Options outstanding |
||
Staking Options exercisable |
||
Incentive Options outstanding |
||
Incentive Options exercisable |
||
Weighted-average remaining contractual term (in years): |
||
Reload Options outstanding |
||
Reload Options exercisable |
||
Staking Options outstanding |
||
Staking Options exercisable |
||
Incentive Options outstanding |
||
Incentive Options exercisable |
Year Ended December 31, 2025 |
||||||||
IPO RLUs |
Incentive RLUs |
|||||||
Restricted
LLC Units
|
Weighted
Average Grant
Date Fair Value
|
Restricted
LLC Units
|
Weighted
Average Grant
Date Fair Value
|
|||||
Unvested at beginning of period |
$ |
$ |
||||||
Granted |
||||||||
Vested |
( |
( |
||||||
Forfeited |
||||||||
Unvested at end of period |
$ |
$ |
||||||
Year Ended December 31, 2025 |
||||||||
Reload Class C
Incentive Units
|
Staking Class C
Incentive Units
|
Class C
Incentive Units
|
Class C Incentive
Units Weighted
Average
Participation
Threshold
|
|||||
Unvested at beginning of period |
$ |
|||||||
Granted |
||||||||
Vested |
( |
( |
( |
|||||
Forfeited |
||||||||
Unvested at end of period |
$ |
|||||||
Year Ended December 31, 2025 |
||||||||
PSUs |
PLUs |
|||||||
Performance
Stock Units
|
Weighted
Average Grant
Date Fair Value
|
Performance
LLC Units
|
Weighted
Average Grant
Date Fair Value
|
|||||
Unvested at beginning of period |
$ |
$ |
||||||
Granted |
||||||||
Vested |
||||||||
Forfeited |
( |
|||||||
Unvested at end of period |
$ |
$ |
||||||
Year Ended December 31, |
||||
2025 |
2024 |
|||
Volatility |
||||
Time to maturity (years) |
||||
Risk-free rate |
||||
RYAN stock price at valuation date |
$ |
$ |
||
Amount |
Weighted Average
Remaining Expense
Period (Years)
|
|||
IPO RSUs |
$ |
|||
Incentive RSUs |
||||
Reload Options |
||||
Incentive Options |
||||
PSUs |
||||
IPO RLUs |
||||
Incentive RLUs |
||||
Reload Class C Incentive Units |
||||
Staking Class C Incentive Units |
||||
Class C Incentive Units |
||||
Total unrecognized equity-based compensation expense |
$ |
Recognized |
|||||
Year Ended December 31, |
|||||
2025 |
2024 |
2023 |
|||
IPO awards |
|||||
IPO RSUs and Staking Options |
$ |
$ |
$ |
||
IPO RLUs and Staking Class C Incentive Units |
|||||
Incremental Restricted Stock and Reload Options |
|||||
Incremental Restricted Common Units and Reload Class C Incentive
Units
|
|||||
Pre-IPO incentive awards |
|||||
Restricted Stock |
|||||
Restricted Common Units |
|||||
Post-IPO incentive awards |
|||||
Incentive RSUs |
|||||
Incentive RLUs |
|||||
Incentive Options |
|||||
Class C Incentive Units |
|||||
PSUs |
|||||
PLUs |
( |
||||
Other expense |
|||||
Director Stock Grants |
|||||
Total equity-based compensation expense |
$ |
$ |
$ |
||
Year Ended December 31, |
||||||
2025 |
2024 |
2023 |
||||
Net income |
$ |
$ |
$ |
|||
Less: Net income attributable to non-controlling interests |
||||||
Net income attributable to Ryan Specialty Holdings, Inc. |
$ |
$ |
$ |
|||
Numerator: |
||||||
Net income attributable to Class A common shareholders |
$ |
$ |
$ |
|||
Add (less): Income attributed to substantively vested RSUs |
( |
|||||
Net income attributable to Class A common shareholders – basic |
$ |
$ |
$ |
|||
Add: Income attributed to dilutive shares |
||||||
Net income attributable to Class A common shareholders – diluted |
$ |
$ |
$ |
|||
Denominator: |
||||||
Weighted-average shares of Class A common stock outstanding –
basic
|
||||||
Add: Dilutive shares |
||||||
Weighted-average shares of Class A common stock outstanding –
diluted
|
||||||
Earnings per share |
||||||
Earnings per share of Class A common stock – basic |
$ |
$ |
$ |
|||
Earnings per share of Class A common stock – diluted |
$ |
$ |
$ |
|||
Year Ended December 31, |
||||||
2025 |
2024 |
2023 |
||||
Conversion of non-controlling interest LLC Common Units1
|
||||||
Conversion of vested Class C Incentive Units1
|
||||||
Class C Incentive Units |
||||||
Year Ended December 31, |
|||||||
Income Statement Caption |
2025 |
2024 |
2023 |
||||
Change in the fair value of the Deal-
Contingent Forward
|
General and administrative |
$ |
$( |
$( |
|||
Total impact of derivatives not
designated as hedging instruments
|
$ |
$( |
$( |
||||
Interest rate cap premium amortization |
Interest expense, net |
$( |
$( |
$( |
|||
Amounts reclassified out of other
comprehensive income related to the
interest rate cap
|
Interest expense, net |
||||||
Total impact of derivatives designated
as hedging instruments
|
$ |
$ |
$ |
||||
As of December 31, |
|||||
Balance Sheet Caption |
2025 |
2024 |
|||
Interest rate cap |
Other current assets |
$ |
$ |
||
As of December 31, 2025 |
As of December 31, 2024 |
|||||||||||
Level 1 |
Level 2 |
Level 3 |
Level 1 |
Level 2 |
Level 3 |
|||||||
Assets |
||||||||||||
Interest rate cap |
$ |
$ |
$ |
$ |
$ |
$ |
||||||
Contingently returnable
consideration
|
||||||||||||
Liabilities |
||||||||||||
Contingent consideration |
||||||||||||
Total assets and liabilities
measured at fair value
|
$ |
$ |
$ |
$ |
$ |
$ |
||||||
Year Ended December 31, |
||||
2025 |
2024 |
|||
Assets |
||||
Balance at beginning of period |
$ |
$ |
||
Newly established assets due to acquisitions |
||||
Total gains included in earnings |
||||
Foreign currency translation adjustments included in OCI |
( |
|||
Settlements |
( |
|||
Balance at end of period |
$ |
$ |
||
Liabilities |
||||
Balance at beginning of period |
$ |
$ |
||
Newly established liabilities due to acquisitions1
|
||||
Total (gains) losses included in earnings |
( |
|||
Foreign currency translation adjustments included in OCI |
||||
Settlements |
( |
( |
||
Acquisition measurement period adjustments |
( |
|||
Balance at end of period |
$ |
$ |
||
Year Ended December 31, |
||||||
2025 |
2024 |
2023 |
||||
United States |
$ |
$ |
$ |
|||
Foreign |
( |
|||||
Income before income taxes |
$ |
$ |
$ |
|||
Year Ended December 31, |
||||||
2025 |
2024 |
2023 |
||||
Current income tax expense (benefit) |
||||||
Federal |
$( |
$ |
$ |
|||
State |
||||||
Foreign |
||||||
Current income tax expense |
$ |
$ |
$ |
|||
Deferred income tax expense (benefit) |
||||||
Federal |
||||||
State |
( |
|||||
Foreign |
( |
( |
( |
|||
Deferred income tax expense |
$ |
$ |
$ |
|||
Total income tax expense (benefit) |
||||||
Federal |
||||||
State |
( |
|||||
Foreign |
( |
|||||
Total income tax expense |
$ |
$ |
$ |
|||
Year Ended December 31, |
||||||||||||
2025 |
2024 |
2023 |
||||||||||
Income taxes at U.S. federal statutory rate |
$ |
$ |
$ |
|||||||||
Nontaxable and nondeductible items |
||||||||||||
Income attributable to non-controlling interests
and nontaxable income
|
( |
( |
( |
( |
( |
( |
||||||
Nondeductible expenses |
||||||||||||
Effect of cross-border tax laws |
( |
( |
( |
( |
||||||||
Changes in valuation allowances |
||||||||||||
Equity-based compensation |
( |
( |
( |
( |
( |
( |
||||||
Common Control Reorganizations1
|
||||||||||||
Change in fair value of contingent consideration2
|
||||||||||||
Other federal |
( |
( |
( |
( |
||||||||
State and local income tax expense (benefit), net
of federal benefit3
|
( |
( |
||||||||||
Foreign tax effects |
||||||||||||
United Kingdom |
||||||||||||
Nondeductible acquisition expenses |
||||||||||||
Nontaxable dividends and profit distributions |
( |
( |
||||||||||
Other |
( |
( |
||||||||||
Spain |
||||||||||||
Nondeductible profit distributions |
||||||||||||
Other |
( |
( |
||||||||||
Other foreign jurisdictions |
( |
( |
||||||||||
Income tax expense |
$ |
$ |
$ |
|||||||||
As of December 31, |
||||
2025 |
2024 |
|||
Deferred tax assets |
||||
Net operating losses |
$ |
$ |
||
Investment in the LLC |
||||
Start-up costs |
||||
Equity-based compensation |
||||
Tax credits |
||||
Capitalized research and development |
||||
Other accrued items |
||||
Total deferred tax assets |
$ |
$ |
||
Valuation allowances |
( |
( |
||
Deferred tax assets, net of valuation allowances |
$ |
$ |
||
Deferred tax liabilities |
||||
Intangibles |
( |
( |
||
Fixed assets |
( |
|||
Other accrued items |
||||
Deferred tax liabilities |
$( |
$( |
||
Net Deferred tax assets |
$ |
$ |
||
Year Ended December 31, |
||||||
2025 |
2024 |
2023 |
||||
Federal |
$ |
$ |
$ |
|||
State and local |
||||||
Texas |
||||||
New York City |
||||||
Other state and local |
||||||
Foreign |
||||||
United Kingdom |
||||||
Netherlands |
||||||
Spain |
||||||
Sweden |
||||||
Other foreign |
||||||
Total cash paid for income taxes, net of refunds |
$ |
$ |
$ |
|||
Exchange Tax
Attributes
|
Pre-IPO M&A
Tax Attributes
|
TRA Payment
Tax Attributes
|
TRA
Liabilities
|
|||||
Balance at December 31, 2023 |
$ |
$ |
$ |
$ |
||||
Exchange of LLC Common Units |
||||||||
Remeasurement – change in state rate |
( |
( |
( |
( |
||||
Remeasurement – foreign tax credits |
( |
( |
||||||
Interest expense |
||||||||
Payments |
( |
( |
( |
( |
||||
Balance at December 31, 2024 |
$ |
$ |
$ |
$ |
||||
Exchange of LLC Common Units |
||||||||
Interest expense |
||||||||
Payments |
( |
( |
( |
( |
||||
Balance at December 31, 2025 |
$ |
$ |
$ |
$ |
Year Ended December 31, |
||||||
2025 |
2024 |
2023 |
||||
Gain on interest rate cap |
$( |
$( |
$( |
|||
Gain on interest rate cap reclassified to earnings |
||||||
Foreign currency translation adjustments |
( |
( |
||||
Change in share of equity method investments’ other
comprehensive income (loss)
|
( |
( |
||||
Gain on Interest
Rate Cap
|
Foreign
Currency
Translation
Adjustments
|
Change in EMI
Other
Comprehensive
Income (Loss)1
|
Total
|
|||||
Balance at December 31, 2022 |
$ |
$ |
$( |
$ |
||||
Other comprehensive income (loss)
before reclassifications
|
( |
|||||||
Amounts reclassified to earnings |
( |
( |
||||||
Other comprehensive income (loss) |
$( |
$ |
$( |
$( |
||||
Less: Non-controlling interests |
( |
( |
( |
|||||
Balance at December 31, 2023 |
$ |
$ |
$( |
$ |
||||
Other comprehensive income (loss)
before reclassifications
|
( |
|||||||
Amounts reclassified to earnings |
( |
( |
||||||
Other comprehensive income (loss) |
$( |
$( |
$ |
$( |
||||
Less: Non-controlling interests |
( |
( |
( |
|||||
Balance at December 31, 2024 |
$ |
$( |
$( |
$( |
||||
Other comprehensive income before
reclassifications
|
||||||||
Amounts reclassified to earnings |
( |
( |
||||||
Other comprehensive income (loss) |
$( |
$ |
$ |
$ |
||||
Less: Non-controlling interests |
( |
|||||||
Balance at December 31, 2025 |
$ |
$ |
$ |
$ |
Year Ended December 31, |
||||||
2025 |
2024 |
2023 |
||||
Net commissions and fees |
$ |
$ |
$ |
|||
Fiduciary investment income |
||||||
Total revenue |
$ |
$ |
$ |
|||
Compensation-related expense1
|
||||||
General and administrative expense2
|
||||||
Other segment items3
|
||||||
Depreciation and amortization |
||||||
Change in contingent consideration |
( |
|||||
Interest income |
( |
( |
( |
|||
Interest expense |
||||||
Income from equity method investments |
( |
( |
( |
|||
Other non-operating loss (income) |
( |
|||||
Income tax expense |
||||||
Net income |
$ |
$ |
$ |
|||
Year Ended December 31, |
||||||
2025 |
2024 |
2023 |
||||
United States |
$ |
$ |
$ |
|||
Foreign |
||||||
Total revenue |
$ |
$ |
$ |
|||
Year Ended December 31, |
||||||
2025 |
2024 |
2023 |
||||
Cash paid for: |
||||||
Interest, net1
|
$ |
$ |
$ |
|||
Non-cash investing and financing activities: |
||||||
Non-controlling interest holders’ tax distributions declared but
unpaid
|
$ |
$ |
$ |
|||
Tax Receivable Agreement liabilities |
||||||
Dividend Equivalents and Declared Distributions liabilities |
||||||
Contingently returnable consideration |
||||||
Contingent consideration liabilities |
||||||
Year Ended December 31, |
||||||
2024 |
2023 |
Total |
||||
Operations and technology optimization |
$ |
$ |
$ |
|||
Compensation and benefits |
||||||
Asset impairment and other termination costs |
||||||
Total |
$ |
$ |
$ |
|||
Operations and
Technology
Optimization
|
Compensation and
Benefits
|
Asset Impairment
and Other
Termination Costs
|
Total |
|||||
Balance at December 31, 2023 |
$ |
$ |
$ |
$ |
||||
Accrued costs |
||||||||
Payments |
( |
( |
( |
|||||
Non-cash adjustments |
( |
( |
||||||
Balance at December 31, 2024 |
$ |
$ |
$ |
$ |
Exhibit
Number
|
Description |
||
3.1 |
|||
3.2 |
|||
4.1 |
|||
4.2 |
|||
4.3 |
|||
4.4 |
|||
4.5 |
|||
4.6 |
|||
4.7 |
|||
10.1 |
10.2 |
|||
10.3 |
+ |
||
10.4 |
+ |
||
10.5 |
|||
10.6 |
+ |
||
10.7 |
+ |
||
10.8 |
+ |
||
10.9 |
+ |
||
10.1 |
+ |
||
10.11 |
+ |
||
10.12 |
+ |
||
10.13 |
+ |
||
10.14 |
+ |
||
10.15 |
+ |
||
10.16 |
|||
10.17 |
|||
10.18 |
|||
10.19 |
+ |
||
19.1 |
|||
21.1 |
|||
23.1 |
|||
31.1 |
|||
31.2 |
|||
32.1 |
* |
||
32.2 |
* |
||
97.1 |
|||
101.INS |
Inline XBRL (Extensible Business Reporting Language) Instance Document – the instance document does
not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL
document.
|
||
101.SCH |
Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents |
||
104 |
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |
Date February 12, 2026
|
|||
Ryan Specialty Holding, Inc |
|||
By: |
/s/ Timothy W. Turner |
||
Timothy W. Turner, Chief Executive Officer |
|||
Signature |
Title |
Date |
/s/ Patrick G. Ryan |
Executive Chairman and Chairman of the Board of Director |
February 12, 2026 |
Patrick G. Ryan | ||
/s/ Timothy W. Turner |
Chief Executive Officer and Director (Principal Executive
Officer)
|
February 12, 2026 |
Timothy W. Turner | ||
/s/ Janice M. Hamilton |
Executive Vice President and Chief Financial Officer
(Principal Financial Officer and Principal Accounting Officer)
|
February 12, 2026 |
Janice M. Hamilton | ||
/s/ Henry S. Bienen |
Director |
February 12, 2026 |
Henry S. Bienen | ||
/s/ David P. Bolger |
Director |
February 12, 2026 |
David P. Bolger | ||
/s/ Michael G Bungert |
Director |
February 12, 2026 |
Michael G. Bungert | ||
/s/ Michelle L. Collins |
Director |
February 12, 2026 |
Michelle L. Collins | ||
/s/ Francesca Cornelli |
Director |
February 12, 2026 |
Francesca Cornelli | ||
/s/ Nicholas D. Cortezi |
Director |
February 12, 2026 |
Nicholas D. Cortezi | ||
/s/ Anthony J. Kuczinski |
Director |
February 12, 2026 |
Anthony J. Kuczinski | ||
/s/ Michael D. O’Halleran |
Director |
February 12, 2026 |
Michael D. O’Halleran | ||
/s/ John W. Rogers, Jr |
Director |
February 12, 2026 |
John W. Rogers, Jr | ||
/s/ Patrick G. Ryan, Jr. |
Director |
February 12, 2026 |
Patrick G. Ryan, Jr. |
| Entity Name | Country of Incorporation / Organization | ||||
| New Ryan Specialty, LLC | United States, Delaware | ||||
| Ryan Specialty, LLC | United States, Delaware | ||||
| Ryan Services Group, LLC | United States, Delaware | ||||
| RSG Underwriting Managers, LLC | United States, Delaware | ||||
| Clach Casualty Underwriting Managers, a series of RSG Underwriting Managers, LLC | United States, Delaware | ||||
| Celerity Risk Solutions, a series of RSG Underwriting Managers, LLC | United States, Delaware | ||||
| Emerald Underwriting Managers, a series of RSG Underwriting Managers, LLC | United States, Delaware | ||||
| Greenhill Underwriting Managers, a series of RSG Underwriting Managers, LLC | United States, Delaware | ||||
| Ryan Financial Lines, a series of RSG Underwriting Managers, LLC | United States, Delaware | ||||
| Life Science Risk, a series of RSG Underwriting Managers, LLC | United States, Delaware | ||||
| Power Energy Risk (PERse), a series of RSG Underwriting Managers, LLC | United States, Delaware | ||||
| Ryan Specialty Transactional Risks US, a series of RSG Underwriting Managers, LLC | United States, Delaware | ||||
| Ryan Specialty Transportation Underwriting Managers, a series of RSG Underwriting Managers, LLC | United States, Delaware | ||||
| Ryan Transactional Risk, a series of RSG Underwriting Managers, LLC | United States, Delaware | ||||
| Ryan Specialty Public Entity, a series of RSG Underwriting Managers, LLC | United States, Delaware | ||||
| Sapphire Blue, a series of RSG Underwriting Managers, LLC | United States, Delaware | ||||
| Technical Risk Underwriters, a series of RSG Underwriting Managers, LLC | United States, Delaware | ||||
| USQRisk, a series of RSG Underwriting Managers, LLC | United States, Delaware | ||||
| Verdant Underwriting Managers, a series of RSG Underwriting Managers, LLC | United States, Delaware | ||||
| WKFC Underwriting Managers, a series of RSG Underwriting Managers, LLC | United States, Delaware | ||||
| RSG Group Program Administrator, LLC | United States, Delaware | ||||
| RSG Specialty, LLC | United States, Delaware | ||||
| Global Special Risks, a series of RSG Specialty, LLC | United States, Delaware | ||||
| Irwin Siegel Agency, a series of RSG Specialty, LLC | United States, Delaware | ||||
| Ryan Alternative Risk, a series of RSG Specialty, LLC | United States, Delaware | ||||
| Ryan Alternative Capital Advisors, a series of RSG Specialty, LLC | United States, Delaware | ||||
| SuiteLife Underwriting Managers, a series of RSG Specialty, LLC | United States, Delaware | ||||
| Trident Marine Managers, a series of RSG Specialty, LLC | United States, Delaware | ||||
| Ryan Specialty Benefits, a series of RSG Specialty, LLC | United States, Delaware | ||||
| US Assure E&S, a series of RSG Specialty, LLC | United States, Delaware | ||||
| Velocity Risk Underwriters, a series of RSG Specialty, LLC | United States Delaware | ||||
| RSG Platform, LLC | United States, Delaware | ||||
| Stetson Insurance Funding, LLC | United States, Delaware | ||||
| Sunstone Assurance II, LLC | United States, Tennessee | ||||
| Sunstone Assurance, LLC | United States, Delaware | ||||
| Sunstone Holdings II, Inc. | United States, Tennessee | ||||
| Sunstone Holdings, Inc. | United States, Delaware | ||||
| Ryan Re Underwriting Managers, LLC | United States, Delaware | ||||
| Ryan Alternative Risk TN Manager LLC | United States, Tennessee | ||||
| AccuRisk Holdings LLC | United States, Delaware | ||||
| Case Management Specialists, LLC | United States, Wisconsin | ||||
| AccuRisk Ancillary Solutions LLC | United States, Delaware | ||||
| Ryan Specialty Benefits Captive, LLC | United States, Vermont | ||||
| AccuRisk Solutions LLC | United States, Delaware | ||||
| AgCentric Insurance Services, LLC | United States, California | ||||
| Matrix Group Benefits, LLC | United States, Maine | ||||
| Matrix Risk Management Services, LLC | United States, Maine | ||||
| U.S. Group & Pension | United States, Maine | ||||
| US Assure, LLC | United States, Delaware | ||||
| US Assure Insurance Services of Florida, LLC | United States, Delaware | ||||
| International Facilities Insurance Services, Inc. | United States, California | ||||
| KRP Managers, LLC | United States, Delaware | ||||
| Concord Specialty Risk of Canada, LLC | United States, Delaware | ||||
| Ryan Specialty Latin America, LLC | United States, Delaware | ||||
| JEM Underwriting Managers, LLC | United States, Delaware | ||||
| Smooth Waters, LLC | United States, Delaware | ||||
| Innovisk Capital Partners, LLC | United States, | ||||
| Inspire Bidco LLC | United States, Delaware | ||||
| Freberg Environmental, LLC | United States, Delaware | ||||
| Corral Insurance Services, LLC | United States, | ||||
| Vindati, LLC | United States, | ||||
| Celerity Professional Liability Insurance Services, LLC | United States | ||||
| Carroll Technical Risks Agency LLC | United States, | ||||
| Innovisk Services, LLC | United States, | ||||
| Velocity Claims, LLC | United States, Delaware | ||||
| Velocity Risk Underwriters, LLC | United States, Delaware | ||||
| Ryan Specialty Holdings International Limited | United Kingdom | ||||
| Ryan Specialty International Limited | United Kingdom | ||||
| Hunter George & Partners Limited | United Kingdom | ||||
| Ryan Specialty Service Centre Limited | United Kingdom | ||||
| RSG Insurance Services of Canada Limited | Canada | ||||
| Ryan Specialty Group Spain Agencia de Suscripcion SL | Spain | ||||
| Keystone Risk Brokerage, LTD | Bermuda | ||||
| Ryan Specialty Newco Holdings Limited | United Kingdom | ||||
| Ryan Specialty (Singapore) Pte Limited | Singapore | ||||
| Ryan Specialty Germany GmbH | Germany | ||||
| Ryan Specialty Underwriting International Managers Limited | United Kingdom | ||||
| Castel Risk Partners (No. 3) LLP | United Kingdom | ||||
| Albus Energy Risks Limited | United Kingdom | ||||
| Transact Risk Partners LLP | United Kingdom | ||||
| Talus Insurance Brokers Limited | United Kingdom | ||||
| Square Pegs Risk Limited | United Kingdom | ||||
| Castel NAPL Limited | United Kingdom | ||||
| Castel Construction Risk Limited | United Kingdom | ||||
| Yachtpod Risks Partners LLP | United Kingdom | ||||
| Paradiso Risks Limited | United Kingdom | ||||
| Maelor Jersey Limited | Jersey | ||||
| Innovisk Topco Limited | United Kingdom | ||||
| Innovisk Midco Limited | United Kingdom | ||||
| Innovisk Bidco1 Limited | United Kingdom | ||||
| Innovisk Bidco2 Limited | United Kingdom | ||||
| Innovisk Capital Partners, LLP | United Kingdom | ||||
| Innovisk (UK) Limited | United Kingdom | ||||
| Innovisk London Limited | United Kingdom | ||||
| Ryan Specialty Australia Pty Limited | Australia | ||||
| Ryan Specialty (DIFC) Limited | Dubai | ||||
| Ryan Specialty Europe GmbH | Germany | ||||
| Ryan Specialty Europe GmbH – UK Branch | United Kingdom | ||||
| Ryan Specialty Europe GmbH – Polish Branch | Poland | ||||
| Ryan Specialty Europe GmbH – Swedish Branch | Sweden | ||||
| Ryan Specialty Europe GmbH – Irish Branch | Ireland | ||||
| Ryan Specialty Europe GmbH – Dutch Branch | Netherlands | ||||
| Ryan Specialty Europe GmbH – Danish Branch | Denmark | ||||
| Ryan Specialty Europe GmbH – Spanish Branch | Spain | ||||
| Innovisk Europe (UK Branch) | United Kingdom | ||||
| Albus Management LLP | United Kingdom | ||||
| Ryan Specialty Corporate Services Limited | United Kingdom | ||||
| Aqueous Management Limited | United Kingdom | ||||
| PFLA Limited | United Kingdom | ||||
| Vertus London Limited | United Kingdom | ||||
| Themis Capital LLP | United Kingdom | ||||
| EXAA Limited | United Kingdom | ||||
| Innovisk India Private Limited | India | ||||
| Velocity Risk International Limited | United Kingdom | ||||
Date: February 12, 2026
|
/s/ Timothy W. Turner |
|
Timothy W. Turner |
||
Chief Executive Officer |
Date: February 12, 2026
|
/s/ Janice M. Hamilton |
|
Janice M. Hamilton |
||
Executive Vice President and Chief Financial
Officer
|
Date: February 12, 2026
|
/s/ Timothy W. Turner |
|
Timothy W. Turner |
||
Chief Executive Officer |
Date: February 12, 2026
|
/s/ Janice M. Hamilton |
|
Janice M. Hamilton |
||
Executive Vice President and Chief Financial
Officer
|